Guggenheim Capital LLC Rocket Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$26.16 - $30.74 $41,986 - $49,337
1,605 Added 19.15%
9,985 $268,000
Q4 2023

Feb 14, 2024
BUY
$16.78 - $31.94 $140,616 - $267,657
8,380 New
8,380 $251,000
Q1 2023

May 10, 2023
BUY
$15.79 - $22.6 $17,163 - $24,566
1,087 Added 10.19%
11,757 $201,000
Q4 2022

Feb 14, 2023
BUY
$15.5 - $22.76 $165,385 - $242,849
10,670 New
10,670 $208,000

Others Institutions Holding RCKT

# of Institutions
213
Shares Held
93.1M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $851M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email